Approvals/TGA/CSL New Zealand Hepatitis B Immunoglobulin-VF (Human Hepatitis B Immunoglobulin), 100IU, solution for injection, vial

Approved

STANDARD

CSL New Zealand Hepatitis B Immunoglobulin-VF (Human Hepatitis B Immunoglobulin), 100IU, solution for injection, vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4ce3771e7ef3bf64
Product Name: CSL New Zealand Hepatitis B Immunoglobulin-VF (Human Hepatitis B Immunoglobulin), 100IU, solution for injection, vial
Artg Id: 125815
Artg Name: CSL New Zealand Hepatitis B Immunoglobulin-VF (Human Hepatitis B Immunoglobulin), 100IU, solution for injection, vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2006-03-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

4ce3771e7ef3bf64

Type

Standard